PFK-2/FBPase-2 (6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase) catalyses the synthesis and degradation of Fru-2,6-P 2 (fructose 2,6-bisphosphate), a key modulator of glycolysis and gluconeogenesis. The PFKFB3 gene is involved in cell proliferation owing to its role in carbohydrate metabolism. In the present study we analysed the mechanism of regulation of PFKFB3 as an immediate early gene controlled by stress stimuli that activates the p38/MK2 [MAPK (mitogen-activated protein kinase)-activated protein kinase 2] pathway. We report that exposure of HeLa and T98G cells to different stress stimuli (NaCl, H 2 O 2 , UV radiation and anisomycin) leads to a rapid increase (15-30 min) in PFKFB3 mRNA levels. The use of specific inhibitors in combination with MK2-deficient cells implicate control by the protein kinase MK2. Transient transfection of HeLa cells with deleted gene promoter constructs allowed us to identify an SRE (serum-response element) to which SRF (serum-response factor) binds and thus transactivates PFKFB3 gene transcription. Direct binding of phospho-SRF to the SRE sequence ( − 918 nt) was confirmed by ChIP (chromatin immunoprecipiation) assays. Moreover, PFKFB3 isoenzyme phosphorylation at Ser 461 by MK2 increases PFK-2 activity. Taken together, the results of the present study suggest a multimodal mechanism of stress stimuli affecting PFKFB3 transcriptional regulation and kinase activation by protein phosphorylation, resulting in an increase in Fru-2,6-P 2 concentration and stimulation of glycolysis in cancer cells.
INTRODUCTION
Enhanced glycolysis is essential for oncogenesis and for the survival and proliferation of cancer cells in the tumour microenvironment. Cancer cells preferentially utilize aerobic glycolysis for energy production and provision of precursors for macromolecule biosynthesis instead of oxidative phosphorylation, even in the presence of oxygen, a phenomenon known as the Warburg effect [1] .
A critical step for high glycolytic rate is the conversion of Fru-6-P (fructose 6-phosphate) into Fru-1,6-P 2 (fructose 1,6-bisphosphate) by PFK-1 (6-phosphofructo-1-kinase). Fru-2,6-P 2 (fructose 2,6-bisphosphate) is the most potent allosteric stimulator of PFK-1 and inhibitor of FBPase-1 (fructose-1,6-bisphosphatase), and hence critically regulates carbohydrate metabolism [2, 3] . PFK-2 (6-phosphofructo-2-kinase)/FBPase-2 (fructose-2,6-bisphosphatase) catalyses both the synthesis and degradation of Fru-2,6-P 2 . In mammals, there are four PFKFB genes (PFKFB1, PFKFB2, PFKFB3 and PFKFB4) which code for the different PFK-2/FBPase-2 isoenzymes characterized by their tissue expression pattern. Moreover, they display different PFK-2/FBPase-2 activity ratios and control by protein kinases.
In cancer cells, the concentration of Fru-2,6-P 2 is generally elevated due to overexpression and activation of PFKFB3 and PFKFB4 [4] [5] [6] [7] [8] . Recently, it has also been reported that androgens elevate Fru-2,6-P 2 concentrations by increasing the kinase activity of PFKFB2 in prostate cancer cells [9] .
The PFKFB3 isoenzyme has the highest PFK-2/FBPase-2 activity ratio, favouring net synthesis of Fru-2,6-P 2 [10] . It is expressed ubiquitously and it is present in proliferating tissues [11] [12] [13] , transformed cells [4, 5, 7, 14] and in various solid tumours and astrocytomas [13, 15] . Moreover, induction of PFKFB3 expression has been reported in response to different stimuli. Among these are hypoxia [7] or progestins [16] , through HIF (hypoxia-inducible factor) or PRE (progesteroneresponse element) interactions within the consensus HRE (hypoxia-response element) or PRE sites of the promoter respectively, growth factors such as insulin [5] , and proinflammatory molecules [4] such as IL (interleukin)-6 [17] , LPS (lipopolysaccharide) and adenosine [18] . Covalent modification by phosphorylation of the C-terminal domain by protein kinases has been reported for PFKFB3, mediated by AMPK (AMPactivated protein kinase) [6, 19] or by RSK (ribosomal S6 kinase) [16] . PFKFB2 is also phosphorylated at the C-terminus by AMPK Abbreviations used: AMPK, AMP-activated protein kinase; ARE, AU-rich element; ChIP, chromatin immunoprecipitation; ERK, extracellular-signalregulated kinase; FBPase-2, fructose-2,6-bisphosphatase; FBS, fetal bovine serum; Fru-6-P, fructose 6-phosphate; Fru-2,6-P 2 , fructose 2,6-bisphosphate; GST, glutathione transferase; HA, haemagglutinin; HEK, human embryonic kidney; Hsp, heat-shock protein; IEG, immediate early gene; IL, interleukin; JNK, c-Jun N-terminal kinase; MAPK, mitogen-activated protein kinase; MEF, mouse embryonic fibroblast; MEK1/2, MAPK/ERK kinase 1/2; MK2, MAPK-activated protein kinase 2; MKK6, MAPK kinase 6; MSK, mitogen-and stress-activated kinase; MS/MS, tandem MS; qPCR, quantitative real-time PCR; PFK-1, 6-phosphofructo-1-kinase; PFK-2, 6-phosphofructo-2-kinase; PI3K, phosphoinositide 3-kinase; PRE, progesterone-response element; RSK, ribosomal S6 kinase; siRNA, small interfering RNA; SRE, serum-response element; SRF, serum-response factor; TCF, ternary complex factor. 1 These authors contributed equally to this work. 2 To whom correspondence should be addressed (email aureanavarro@ub.edu).
[20], PKA (protein kinase A) or PKB (protein kinase B; also known as Akt) [21, 22] . However, the role of phosphorylation of PFKFB proteins by protein kinases in proliferating cancer cells has been little studied. MAPKs (mitogen-activated protein kinases) are among the most ancient signal transduction pathways and are widely used throughout evolution in many physiological processes. Human tumours and cancer cell lines often show altered expression of MAPKs. These protein kinases affect a large number of processes, such as cell survival, apoptosis, differentiation, inflammation and migration, among others. Generally, their effect depends on the cellular context and may contribute to tumorigenesis [23] .
Cellular stresses activate multiple MAPK cascades and affect the transcription of IEGs (immediate early genes). MAPKs regulate IEG expression in a stimulus-dependent manner [23] . In mammalian cells, three different MAPK families have been characterized: ERK (extracellular-signal-regulated kinase), JNK (c-Jun N-terminal kinase)/SAPK (stress-activated protein kinase) and p38 kinase. Also in mammals, the four p38 isoforms are strongly activated by environmental stresses and inflammatory cytokines, including oxidative stress, UV irradiation, heat shock, hyperosmolarity, hypoxia, ischaemia, IL-1 and TNFα (tumour necrosis factor α) [24] . Activated p38α promotes MK2 (MAPKactivated protein kinase 2) phosphorylation at Thr 222 , Ser 272 and Thr 334 , and the MK2 structure suggests that Thr 334 phosphorylation may serve as a switch for MK2 nuclear import and export [25] .
MK2 was shown to contribute to the phosphorylation of SRF (serum-response factor). Comparison of wild-type and MK2-deficient cells revealed that MK2 is the major SRF kinase induced by stress, suggesting a role for MK2 in the stress-mediated IEG response [23, 26] . SRF is a member of the MADS box family of transcription factors [27, 28] . SRF regulates gene expression by binding as a homodimer to a sequence motif termed the CArG box [CC(A/T)6GG], which has been associated primarily with growth (e.g. c-Fos and JunB), muscle-specific differentiation and cytoskeletal (e.g. Tagln and Acta2) gene expression [29] .
In the present paper we report that exposure of HeLa and T98G cells to different stress stimuli (NaCl, H 2 O 2 , UV radiation or anisomycin) leads to a rapid increase in PFKFB3 mRNA levels, PFK-2 activity and Fru-2,6-P 2 concentration. The results obtained suggest a dual mechanism co-ordinated by MK2 affecting PFKFB3 protein phosphorylation and gene regulation to rapidly enhance glycolysis in response to stress stimuli in cancer cells.
EXPERIMENTAL

Reagents, antibodies and Western blot analysis
Anisomycin was purchased from Sigma and used at a final concentration of 400 ng/ml. NaCl was obtained from Merck and used at a final concentration of 0.2 M. H 2 O 2 was from Sigma and used at 200 μM. FBS (fetal bovine serum) was obtained from Biological Industries. The MAPK inhibitors SB203580 and PD98059 (Calbiochem), and wortmannin (Sigma-Aldrich) were used at final concentrations of 10 nM, 10 nM and 100 nM respectively. The JNK inhibitor SP600125 (A.G. Scientific) and MK2 inhibitor PF3644022 (Sigma) were each used at final concentrations of 10 nM. MAPK inhibitors were added to cell culture medium 30 min before stimulation (anisomycin, NaCl, H 2 O 2 , UV irradiation and 20 % FBS). Actinomycin D (Merck) was used at a final concentration of 5 μg/μl. Antibodies against phospho-ERK1/2, total ERK, phospho-p38α, phospho-MK2 (Thr  334 ) , total MK2, phospho-SRF (Ser 103 ), total SRF (all from Cell Signaling Technology) and phospho-Hsp (heat-shock protein) 25 (Invitrogen) were used at a dilution of 1:1000.
Other antibodies used were against α-tubulin (Sigma) (1:4000 dilution) and HA (haemagglutinin; Sigma) (1:1000 dilution), and a specific polyclonal antibody recognizing the C-terminus of PFKFB3 (1:6000 dilution) was obtained as described by Riera et al. [5] . Two rabbit polyclonal anti-phospho-PFKFB3 (Ser 461 ) and anti-phospho-PFKFB3 (Ser 478 ) (1:200 dilution) antibodies were obtained as described in [16] . Western blot analysis was carried out as described in [16] .
Cell culture
HeLa cells (from A.T.C.C.), T98G cells (from A.T.C.C.), and MK2-deficient and wild-type cells (a gift from Dr M. Gaestel, Hannover Medical School, Hannover, Germany) were maintained in DMEM (Dulbecco's modified Eagle's medium; Biological Industries) supplemented with 10 % FBS, 10 000 units/ml penicillin, 10 mg/ml streptomycin and 0.2 mM L-glutamine and incubated in a humidified atmosphere of 5 % CO 2 at 37
• C. In all cases, cells were cultured in serum-deprived medium for 24 h before stimulation.
qPCR (quantitative real-time PCR) analysis
Total RNA was isolated from HeLa, T98G and MEF (mouse embryonic fibroblast) cells according to the manufacturer's protocol (Ultraspec RNA Biotecx Laboratories). RNA manipulation and qPCR analysis were performed as described in [16] . The relative expression of each gene was normalized to that of 18S (probe/primer Hs99999901_s1). Human PFKFB1 (probe/primer Hs00159997_m1), PFKFB2 (probe/primer Hs00359506_g1), PFKFB3 (probe/primer Hs001890079_m1) and PFKFB4 (probe/primer Hs00190096_m1) were from Applied Biosystems.
Fru-2,6-P 2 and lactate determination
Fru-2,6-P 2 determination was performed as described in [30] . Lactate was measured spectrophotometrically [31] in 1 ml of supernatants from cells treated for 8 h.
PFK-2 assay
Following phosphorylation of recombinant PFKFB3 (see below), aliquots of reaction mixture (20 μl) were assayed for PFK-2 activity in a final volume of 200 μl containing 1 mM fructose phosphate/3 mM glucose 6-phosphate, 5 mM MgATP, 1 mM dithiothreitol, 5 mM potassium phosphate, 100 mM potassium chloride, 20 mM potassium fluoride, 1 mg/ml BSA and 50 mM Tris/HCl (pH 7.1) at 30
• C. The reactions were stopped at different times by adding 200 μl of 100 mM sodium hydroxide followed by heating at 80
• C for 10 min. Aliquots were then taken for the measurement of Fru-2,6-P 2 . One unit of PFK-2 activity is the amount that catalyses the formation of 1 μmol of Fru-2,6-P 2 per min under the assay conditions.
Plasmid constructs
To study promoter regions, we used the recombinant plasmid PFKFB3/ − 3566 and deleted constructs PFKFB3/ − 2492, PFKFB3/ − 1408, PFKFB3/ − 938 and PFKFB3/ − 648 of the PFKFB3 gene promoter cloned into pGL2basic (Promega) using the luciferase gene as a reporter. A pGL2basic vector with the c-fos minimal promoter unit served as the basis for reporter constructs cfos-SRE-wt and cfos-SRE-Mut (wt is wild-type; SRE is serum-response element). A fragment of 30 nt of the PFKFB3 promoter (from − 934 to − 904) with the sequence 5 -GAATTTTAGGAGTCTGCCTAATAAGGGGCC-3 (containing the putative SRE marked in bold type) was subcloned to obtain the cfos-SRE-wt construct. The same 30 nt fragment with a mutation in 4 bp of the SRE-binding site (underlined) (5 -GAATTTTAGGAGTCTGCAGAATACAGGGCC-3 ) was used for the cfos-SRE-Mut construct. The identity of cloned products was confirmed by nucleotide sequence analysis. Myctagged PFKFB3 was generated for immunoprecipitating PFKFB3 using an anti-Myc antibody. HA-tagged PFKFB3 plasmid expression vector was generated to monitor PFKFB3 expression using an anti-HA antibody. HA-PFKFB3 was used as a parental plasmid to generate phosphorylation site mutants using PCR approaches. Expression vectors coding constitutively active MKK6 (MAPK kinase 6) was provided by Dr P. Muñoz-Canoves (Pompeu Fabra University, Barcelona, Spain). Constitutively active MK2(EE) and catalytically inactive MK2( − ) were a gift from Dr Angel R. Nebreda (IRB, Barcelona, Spain).
Transfection and luciferase assays
Cell transfection was performed using Lipofectamine TM 2000 (Invitrogen) for T98G and MEF cell lines (following the manufacturer's protocol). HeLa cells were transfected with PEI (polyethyleneimine). The different promoter/reporter plasmids (2 μg) and 0.25 μg of pSV40-β-galactosidase control vector (Promega) were co-transfected into six-well plates containing 70-80 % confluent cells. After 4 h, cell medium was replaced by complete medium. After another 4 h, the cells were distributed into 24-well plates and maintained overnight in complete medium. The cells were starved for 24 h and treated as indicated. At various times, the cells were washed twice with PBS and lysed in buffer. Luciferase activity was measured as described in [16] .
ChIP (chromatin immunoprecipitation)
ChIP assays were performed using chromatin from HeLa cells treated with anisomycin for 0, 10 and 30 min, as described in [16] . The primer sequence used for the PCR was PFKFB3 (5 -CTGTCACAAGTCGCGAGCTG-3 ). The antibody used was phospho-SRF (Ser 103 ) (Cell Signaling Technology).
Immunoprecipitation and kinase assay, and content and enzyme assay
For immunoprecipitation assays, HeLa cells were transiently transfected with Myc-PFKFB3. Immunoprecipitation and kinase assays were perfomed as described in [16] . Content and enzymatic assays were performed as described in [22] .
In vitro phosphorylation by MK2
Activated MK2 (0.25 unit/ml) (Millipore) was incubated with 1 μg of purified GST (glutathione transferase)-PFKFB3 in 60 μl of reaction mixture containing 50 mM sodium-β-glycerol phosphate, 10 mM MgCl 2 , 2 mM dithiothreitol and 0.1 mM EGTA (pH 7.5) supplemented with 0.1 mM [γ -32 P]MgATP (specific radioactivity 1000 c.p.m./pmol) at 30
• C for 40 min. Proteins were separated by SDS/PAGE (10 % gels) for staining with PAGEBlue TM (Thermo Scientific). PFKFB3 protein was quantified by gel IR imaging (LI-COR Odyssey TM ) along with known amounts of rabbit aldolase whose concentration had been determined from the calculated molar absorption coefficient and the measured absorbance at 280 nm [32] . For determination of 32 P incorporation, PFKFB3 bands were excised from the gel, dissolved in 500 μl of 3% (w/v) H 2 O 2 (Sigma) by heating for 2 h at 80
• C, mixed with 5 ml of scintillant (Ultima Gold TM ; PerkinElmer) and radioactivity was counted. Stoichiometries of phosphorylation were expressed as mol of 32 P incorporated/mol of PFKFB3 using the calculated molecular mass of the tagged PFKFB3 isoenzyme.
Phosphorylation site identification by MS
GST-PFKFB3 (5 μg) was incubated as described above with 50 m-units of activated MK2 and 0.1 mM [γ -
32 P]ATP (specific radioactivity 2000 c.p.m./pmol) for 60 min at 30
• C. After SDS/PAGE, bands corresponding to phosphorylated PFK-2 were excised from the gel and digested with trypsin [33] . Peptides were separated by reverse-phase narrow-bore HPLC at a flow rate of 200 μl/min. Radioactive peaks were detected by Cerenkov counting and analysed by nano-ESI (electrospray ionization) MS/MS (tandem MS) in a LCQ Deca XP Plus ion-trap mass spectrometer (Thermo Scientific).
RNAi (RNA interference)
siRNA (small interfering RNA) oligonucleotides targeting PFKFB2, PFKFB3 and control siRNA were purchased from Shangai GenePharma and Invitrogen respectively. The siRNA oligonucleotide sequences were: PFKFB2, 5 -AGAGCAAG-AUAGUCUACUATT-3 ; PFKFB3, 5 -AGCUGCCUGGACAA-AACAUG-3 ; and negative control siRNA, 5 -UUCUCCG-AACGUGUCACGUTT-3 . Transfections were performed with Oligofectamine TM (Invitrogen) as specified by the manufacturer.
Data analysis
Results shown are the means+ − S.E.M. for the values obtained from at least three independent experiments. Differences between groups were analysed by Student's t test (*P < 0.05, **P < 0.01 and ***P < 0.001, for stress stimulated cells or transfected cells compared with basal conditions; and #P < 0.05, ##P < 0.01 and ###P < 0.001, for stress plus inhibitor-treated compared with stress-treated cells.
RESULTS
PFKFB3 expression is up-regulated by the p38/MK2 pathway after stress stimuli
We tested whether stress stimuli-activated MAPK can regulate PFKFB3 mRNA transcription. First, we performed qPCR using a specific probe against human PFKFB3 cDNA. Treatment with anisomycin, NaCl, H 2 O 2 or UV significantly increased PFKFB3 mRNA levels at 30 min ( Figure 1A ). Similar results were obtained using T98G cells treated in the same way (Supplementary Figure  S1A at http://www.biochemj.org/bj/452/bj4520531add.htm). To for three experiments (**P < 0.01; ***P < 0.001).
achieve a more detailed pattern of mRNA expression, we selected anisomycin or NaCl treatments and evaluated PFKFB3 mRNA expression at different times in HeLa ( Figure 1B ) and T98G (Supplementary Figure S1B) cells. PFKFB3 mRNA levels were significantly increased at 15 min by both treatments in HeLa cells, whereas in T98G cells the increase in mRNA levels was not seen until 30 min after the addition of NaCl. qPCR using specific probes for human PFKFB2, PFKFB3 and PFKFB4 in both cell types showed that PFKFB3 mRNA was the only isoenzyme modified after anisomycin and NaCl treatment, whereas other PFKFB isoforms remained unchanged ( Figure 1C and Supplementary Figure S1C ). In both cell types, the levels of PFKFB1 were undetectable. To probe whether PFKFB3 mRNA induction depended on p38 MAPK cascade activation, we pre-treated HeLa cells with the specific p38 inhibitor SB203580 before treatment with anisomycin or NaCl.
As shown in Figure 1(D) , at both time points tested (30 and 120 min), the inhibition of p38 activity kept PFKFB3 mRNA levels similar to basal levels after anisomycin treatment and also significantly reduced mRNA levels after NaCl treatment in HeLa cells. The same experimental design was carried out using the MEK1/2 (MAPK/ERK kinase 1/2) inhibitor PD98059, the PI3K (phosphoinositide 3-kinase) activity inhibitor wortmannin, and the JNK inhibitor SP600125, before treatment for 30 and 120 min. No significant effect on PFKFB3 mRNA was observed with any of these inhibitors, suggesting that these pathways do not significantly contribute towards the control of PFKFB3 expression. Similar results were obtained when identical experiments were performed in T98G cells (Supplementary Figures S1D and S1E ).
To discriminate between a direct role of p38 or the possibility that other protein kinases downstream of p38 were responsible for increasing PFKFB3 transcription, other inhibitors were compared with results obtained with SB203580. As shown in Figure 1 (E) and Supplementary Figure S1(F), when H89, a known MSK (mitogen-and stress-activated kinase) inhibitor, was used in the presence of anisomycin or NaCl treatment, there was no change in PFKFB3 activation in HeLa or T98G cells. However, the use of PF3644022, a specific MK2 inhibitor, abolished the increase in PFKFB3 mRNA in both cell lines treated with anisomycin or NaCl ( Figure 1F and Supplementary Figure S1G) .
To explore further the participation of MK2 in the transcriptional regulation of PFKFB3, we used a MEF cell line in which MK2 had been deleted. Basal expression of PFKFB3 in wildtype and MK2-deficient cells showed no differences between them (results not shown). We observed a 5-fold increase in PFKFB3 gene expression 1 h after the addition of anisomycin in wild-type cells, whereas no induction was observed in MK2-deleted cells (Figure 2A ). Treatment of wild-type cells with the p38 inhibitor SB203580 before stimulation with anisomycin significantly reduced PFKFB3 mRNA transcription. In contrast, when MK2-deficient cells were transiently transfected with an expression vector encoding constitutively active MK2, we observed a 2.5-fold increase in endogenous PFKFB3 gene expression. Similar results were obtained by transfecting wild-type cells (Figure 2A) .
We next analysed mRNA stability by comparing transcript levels after anisomycin stimulation in the presence and absence of the transcriptional inhibitor actinomycin D. PFKFB3 mRNA was stable at all conditions tested, except those treated with anisomycin alone ( Figure 2B ).
p38/MK2 pathway mediates PFKFB3 promoter activation
The absence of MK2-dependent PFKFB3 mRNA stabilization suggested a role for MK2 in PFKFB3-induced transcriptional activation by stress. Using a full-length PFKFB3/ − 3566 reporter construct transfected into HeLa cells, we observed a 1.5-fold increase in luciferase activity after anisomycin treatment. Cotransfection with MKK6 or MK2(EE) expression vectors also resulted in significant activation (5-or 4-fold respectively), whereas no effect was seen when MK2( − ) was used ( Figure 3A) . FBS or anisomycin treatment resulted in a 1.7-fold activation which was inhibited when SB203580 was used in cells stimulated with anisomycin.
We attempted to determine the minimal promoter region required for this response. As shown in Figure 3 
Then, HeLa cells were transiently co-transfected with promoter constructs PFKFB3/ − 3566 and PFKFB3/ − 2494 together with a catalytically defective MK2 expression vector [MK2-K79R or MK2( − )]. Co-transfection with constitutively active MK2 expression vector was used as a control. Figure 3 (C) indicates that there was no significant increase in luciferase activity when the defective MK2 expression vector was used. These data suggest that catalytic activity of MK2 is necessary to induce PFKFB3 gene expression.
To probe the anisomycin responsiveness of the SRE sequence located at the region from − 934 to − 904, we subcloned these 30-nt, as described in the Experimental section, to generate cfos-SRE-wt and cfos-SRE-Mut constructs. Figure 3(D) shows a 5-fold increase in luciferase activity of HeLa cells transfected with the cfos-SRE-wt construct, whereas the cfos-SRE-Mut construct had no effect after anisomycin or FBS treatment. Likewise, cotransfection of these c-Fos constructs, together with constitutively active MK2 expression, resulted in a significant increase only with the cfos-SRE-wt construct. Wild-type and mutated constructs displayed similar basal reporter activities (results not shown). To confirm the importance of this SRE sequence of the PFKFB3 promoter for the MK2-dependent stress response, we used another approach involving either the wild-type MEF cell line or the MK2-deleted cells. As expected, only the MK2 wild-type cell line displayed increased luciferase activity after treatment either with anisomycin or 20 % FBS when transfected with cfos-SRE-wt ( Figure 3D ). In contrast, the transfected cfos-SRE-Mut displayed no increased luciferase activity after the same treatment. Moreover, in MK2-deficient cells, 20 % FBS or anisomycin treatment failed to increase luciferase activity with either the wildtype or mutated cfos-SRE constructs. Interestingly, a significant increase in luciferase activity was observed when cfos-SRE-wt was co-transfected with MK2(EE) expression vector in MK2-deleted cells.
SRF binds to the SRE in the PFKFB3 promoter
As SRF is one of the several in vitro substrates of MK2, SRF phosphorylation at Ser 103 after p38 and MK2 activation by anisomycin treatment was tested (Supplementary Figure  S2 at http://www.biochemj.org/bj/452/bj4520531add.htm). SRF recruitment to the endogenous promoter was studied by ChIP, using an anti-phospho-SRF (Ser 103 ) antibody. ChIP analysis demonstrated phospho-SRF recruitment at the region flanking the SRE ( − 934 to − 904) of the PFKFB3 promoter in response to anisomycin treatment in HeLa cells ( Figure 4A ). Inputs were used for normalization and a densitometric analysis was performed to quantify differences between samples after different times of anisomycin treatment ( Figure 4B ). Increased recruitment of phospho-SRF after 10 and 30 min of anisomycin treatment to the PFKFB3 promoter was observed. The same ChIP experiments were carried out in the presence of the p38 inhibitor SB203580, showing reduced recruitment. Together, the results indicate that activated SRF binds to the SRE sequence of the PFKFB3 promoter to increase mRNA transcription in response to stress stimuli.
Metabolic effects of p38/MK2-mediated PFKFB3 activation
To examine the effects of p38/MK2 pathway activation on PFKFB3 protein expression, Western blot analysis was performed. A significant increase in total PFKFB3 protein was observed at 2 h after anisomycin treatment in HeLa cells ( Figure 5A ). Elevated PFKFB3 protein levels were also seen in T98G cells, which was still maintained at high levels at 8 h (Supplementary Figure S3A at http://www.biochemj.org/ bj/452/bj4520531add.htm). To confirm the physiological role of PFKFB3 induction, we measured Fru-2,6-P 2 concentrations. HeLa and T98G cell lines treated with different stress stimuli (anisomycin, NaCl, H 2 O 2 and UV) showed increased Fru-2,6-P 2 concentrations already after 15 min of treatment ( Figure 5B and Supplementary Figure S3B) . To investigate the mechanism responsible for the rapid increase in Fru-2,6-P 2 concentration, we tested PFK-2 activation via phosphorylation by the p38 MAPK pathway. Figure 5 (C) shows PFKFB3 phosphorylation at Ser 461 , whereas phosphorylation of Ser 478 remained unaffected. At the same time, p38 MAPK, MK2, Hsp25 and SRF phosphorylation was also observed. In addition, anisomycin treatment also , phospho-p38, phospho-Hsp25, phospho-ERK1/2 and total ERK were used as indicated. The histogram represents the densitometry of three independent experiments expressed as the fold change against 0 h (basal conditions) (*P < 0.05 and **P < 0.01). activated ERK1/2 and JNK MAPKs ( Figure 5C ). Treatment of HeLa cells with NaCl also led to PFKFB3 phosphorylation at Ser 461 ( Figure 5D ). To study the MAPK pathway involved in increasing Fru-2,6-P 2 synthesis, T98G and HeLa cells were pre-treated with different inhibitors and incubated for 15 or 120 min. Only inhibition of the p38 MAPK (with SB203580) and MK2 (with PF3644022) abrogated the increase in Fru-2,6-P 2 after anisomycin or NaCl treatment ( Figure 6A and Supplementary Figure S4A at http://www.biochemj.org/bj/452/bj4520531add.htm). Similar results were obtained in T98G cells (Supplementary Figures  S3C and S3D) . The same MAPK inhibitors were tested by immunobloting to see whether the phosphorylation of PFKFB3 by anisomycin was due to activation of one or more of these pathways. HeLa cells were pre-treated with the p38 inhibitor SB203580 before stimulation with anisomycin. Ser 461 phosphorylation was markedly decreased by the inhibitor. Pretreatment with the ERK inhibitor PD98059 or the JNK inihibitor SP600125 did not result in significant changes in PFKFB3 phosphorylation ( Figure 6B ). Similar results were obtained when HeLa cells were treated with NaCl (Supplementary Figure S4B) . Moreover, when these cells were pre-treated with the MK2 specific inhibitor PF3644022 before anisomycin treatment, PFKFB3 phosphorylation on Ser 461 was abrogated ( Figure 6C ). In all cases, the histograms represent the densitometry of three independent experiments expressed as the fold change against 0 h (basal conditions) (**P < 0.01 and ***P < 0.001, for anisomycin-treated cells with respect to basal conditions; #P < 0.05, ##P < 0.01 and ###P < 0.001, for anisomycin plus inhibitor-treated cells with respect to anisomycin-treated cells).
Taken together, these results implicate the participation of the p38 MAPK/MK2 pathway in the phosphorylation of Ser 461 of PFKFB3 after stress stimuli in cancer cells.
It is known that cells can express more than one PFKFB isoenzyme concomitantly, as in HeLa cells [14] . As the only isoenzyme significantly up-regulated by anisomycin and NaCl is PFKFB3 (Figure 1D) , we checked the contribution of this isoenzyme towards the increase in Fru-2,6-P 2 measured after anisomycin or NaCl treatment. RNA silencing of PFKFB3 expression in HeLa cells ( Figure 7A ) blocked the anisomycininduced increase in Fru-2,6-P 2 concentration ( Figure 7B ).
MK2 phosphorylates PFKFB3 at Ser 461 in vitro
Stress-activated proline-directed kinases such as p38 and JNK are known to target the sequence (P)-X-S*/T*-P-X [34, 35] , but this sequence is not present around Ser 461 of PFKFB3. The sequence surrounding Ser 461 of PFKFB3 lies in a suitable consensus site for phosphorylation by MK2 [ -Xaa-Arg-Xaa-(Leu/Asn)-pSer/Thr-(Ile/Val/Phe/Leu)-Xaa], where is a bulky hydrophobic residue [23] . As shown in Figure 8(A) , the sequence is LMRRNSVT (the conserved residues are underlined) and might be targeted by MK2. Recombinant constitutively active MK2 phosphorylated GST-PFKFB3 in a time-dependent manner ( Figure 8B ). The stoichiometry of phosphorylation tended towards 0.3 mol of phosphate incorporated/mol of subunit protein after 40 min of incubation, which is slightly higher than the stoichiometry (0.2, mol/mol) obtained with AMPK, used as positive control. We then tested whether phosphorylation of PFKFB3 had any effect on PFK-2 activity ( Figure 8C ). Phosphorylation of PFKFB3 by MK2 increased the V max of PFK-2 approximately 2.5-fold ( Figure 8D) , also decreasing the K m for its substrate (Fru-6-P). In order to identify the Figure S5B) . This site corresponds to Ser 461 phosphorylated by AMPK [6, 19] . To investigate the physiological relevance of PFKFB3 Ser 461 phosphorylation, we generated site-specific mutants where Ser 461 was replaced by alanine (S461A) or glutamate (S461E). Mutagenesis was carried out using a PFKFB3 expression vector containing an HA tag. Three cancer cell lines, HeLa, T98G and MCF7 cells, were transiently transfected with the expression vectors HA-PFKFB3 (wild-type), HA-PFKFB3 (S461A) and HA-PFKFB3 (S461E) and the Fru-2,6-P 2 concentration was determined. As shown in Figure 8 (E), only the mutant mimicking Ser 461 phosphorylation (S461E) significantly increased Fru-2,6-P 2 concentrations compared with the transfected wild-type construct. Moreover, we measured the concentration of lactate in the medium in these cell lines transfected with the same expression vectors and similar results were obtained ( Figure 8F ). Next, we determined PFK-2 activity of the Ser 461 PFKFB3 mutants which where transiently transfected in HEK (human embryonic kidney)-293 cells and then immunoprecipitated with an anti-HA antibody. Once purified, these constructs were used in a kinase assay with constitutively active MK2, and then PFK-2 activity was measured. HA-PFKFB3 was used as a control because it was the original expression vector from which the site-directed mutants were generated. The concentration of Fru-2,6-P 2 obtained with the control vector HA-PFKFB3 was lower than that acquired with the GST-PFKFB3 used in previous assays; so we cannot compare the concentration of Fru-2,6-P 2 of the mutants with GST-PFKFB3. Figure 8(G) shows that only when Ser 461 of PFKFB3 is phosphorylated by MK2, or this phosphorylation is mimicked by the substitution of Ser 461 by glutamate, there is an increase in Fru-2,6-P 2 , whereas the Ser 461 to alanine mutation produced no increase in metabolite concentration, even when this construct was incubated with constitutively active MK2.
Stress-induced MK2 activation leads to phosphorylation of PFKFB3 at Ser 461 in intact cells
Next, we used different approaches to examine whether the activation of MK2 in intact cells was sufficient to induce the phosphorylation and activation of endogenous PFKFB3. First, MK2 wild-type and MK2-deleted MEF cells were serum-starved and treated with anisomycin (400 ng/ml) for 30 min. Where indicated, SB203580 was added 30 min before anisomycin treatment and Fru-2,6-P 2 levels were measured. As expected, we observed a significant increase in Fru-2,6-P 2 concentration in the presence of anisomycin in the MK2 wild-type MEF cell line, which was abrogated in the presence of the SB203580 inhibitor ( Figure 9A ). MEF MK2-deleted cells displayed basal Fru-2,6-P 2 concentrations lower than in MK2 wild-type cells and were unresponsive to anisomycin stimulation ( Figure 9A ). PFKFB3 phosphorylation increased in parallel with Fru-2,6-P 2 and was abrogated by the inhibitor. No changes in the phosphorylation of PFKFB3 at Ser 461 were observed in MEF MK2-deficient cells ( Figure 9B ). Owing to the low levels of expression of PFKFB3 in these MEF cell lines, we transfected them with an expression vector tagged with FLAG (3FLAG-PFKFB3). When MK2-deleted cells were co-transfected with 3FLAG-PFKFB3 together with constitutively active MK2, PFKFB3 Ser 461 phosphorylation was detected, indicating a rescue for MK2-deficient cells. However, Ser 461 phosphorylation of PFKFB3 was unaffected when the cells were co-transfected with 3FLAG-PFKFB3 together with a kinase-inactive MK2 ( Figure 9C ).
Finally, we took cell lysates from HeLa cells, stimulated with or without anisomycin, and then immunoprecipitated MK2. Purified immunoprecipitates were incubated with previously purified Myc-PFKFB3 in the presence or absence of Mg-ATP for 45 min at 30
• C. Under these conditions, phosphorylation of PFKFB3 at Ser 461 significantly increased in MK2 immunoprecipitates from cells stimulated with anisomycin ( Figure 9D ). The results demonstrate that MK2, activated by stress stimuli, phosphorylates Ser 461 of PFKFB3, thus increasing its activity.
DISCUSSION
Growth factors, inflammatory cytokines and various chemical and physical stresses rapidly induce the transcription activation of IEGs in mammalian cells. IEG expression is co-ordinated by multiple MAPK signalling pathways in a specific manner [23] . Several kinases activated by p38 MAPK are involved in the control of gene expression at different levels [24] . MK2 has been classically linked to the control of gene expression at the post-transcriptional level, by phosphorylating the ARE (AU-rich element)-binding protein TTP (tristetraprolin). Nevertheless, some transcription factors, such as E47, ER81, SRF and CREB (cAMP-response-element-binding protein), are also phosphorylated by MK2 [36] and a new function of MK2 in transcriptional activation of IEGs, via the p38α/MK2/SRF axis, has been proposed [37] . These authors demonstrate that the regulation of some IEGs, such as early growth factors (egr2, egr3) and jun-B, by MK2 involve SRF and its binding to SRE.
In the present study, we show that different stress stimuli, such as anisomycin, NaCl, H 2 O 2 or UV radiation, up-regulate PFKFB3 gene expression in two cancer cell lines (HeLa and T98G). Lactate concentration was determined enzymatically for 8 h after serum deprivation. The results were normalized to protein concentration and expressed as the fold change compared with the control. (G) HEK-293 cells were transiently transfected with the expression vectors HA-PFKFB3, HA-PFKFB3 (S461A) and HA-PFKFB3 (S461E) or not transfected (basal) and then were immunoprecipitated with an anti-HA antibody to measure PFK-2 activity. Immunoprecipitated constructs were incubated in the presence or absence of constitutively active MK2. The results were normalized to protein concentration and expressed as pmol of Fru-2,6-P 2 /mg of protein (*P < 0.05, **P < 0.01 and ***P < 0.001; + P < 0.05, + + P < 0.01, + + + P < 0.001).
PFKFB3 mRNA is rapidly increased by these stress stimuli (within 30 min), behaviour typical of IEGs that are regulated by MAPK pathways in a stimuli-dependent manner [23] . Some of these stimuli activate more than one MAPK pathway, mainly ERK, JNK and p38 MAPKs. However, we demonstrate that PFKFB3 transcriptional activation by anisomycin and NaCl treatment are mainly dependent on p38 MAPK activation, since the mRNA increment is abrogated by the p38 MAPK-specific inhibitor SB203580, and it is unaffected by treatment with MEK1/2 (PD98059) or JNK (SP600125) inhibitors.
In addition, to test whether other MAPKs downstream of p38 were the responsible for PFKFB3 transcription activation, we used a known MSK-1 inhibitor (H89) and PF-3644022, a specific MK2 inhibitor, both in the presence of anisomycin and NaCl treatments. Although no change was observed with H89, PF3644022 abolished PFKFB3 mRNA induction under both treatments and in both cell types (HeLa and T98G). Furthermore, qPCR results, using MEF MK2-deficient compared with wild-type cells, demonstrated that the presence of MK2 is required for endogenous PFKFB3 mRNA induction. Similarly, the transfection and overexpression of constitutively active MK2 was sufficient to increase the expression of endogenous PFKFB3 mRNA in MK2-deleted cells, indicating that MK2 is required for PFKFB3 gene induction after anisomycin treatment.
The PFKFB3 gene contains multiple copies of the AUUUA sequence (AREs) in the 3 -untranslated region. MK2 has been classically linked to the control of gene expression through the stabilization of mRNAs via AREs sequences present in its target genes [25] . For this reason, we tested whether MK2 could stabilize PFKFB3 mRNA. We studied changes in PFKFB3 mRNA in HeLa cells in the presence of the transcriptional inhibitor actinomycin D, either in the presence or absence of anisomycin treatment. PFKFB3 mRNA levels were not affected by actinomycin D, suggesting that stress induction of PFKFB3 is independent of mRNA stability, at least at the short times used in the present study. However, this does not exclude lower PFKFB3 stability in other cells under different experimental conditions.
As recent work suggests that p38-mediated activation of MK2/3 kinases can also contribute to stress-induced gene expression [37] , we next focused on PFKFB3 promoter regulation based through a putative SRE (CCTAATAAGG) located at position − 917 relative to the transcription start site in the 5 -flanking region. Different experimental approaches confirm that this 30-nt sequence is essential for the PFKFB3 response to MK2 activation. Finally, ChIP analysis demonstrated the binding of phospho-SRF to the PFKFB3 promoter.
SRF has been linked to two families of cofactors, the TCFs (ternary complex factors) and the MTRFs (myocardin-related transcription factors), which are regulated by separate signalling pathways and thereby differentially control SRF target genes [38] . In the case of the PFKFB3 gene, we cannot confirm the participation of these cofactors. First, there is only a partial TCF consensus sequence around the SRF region in the PFKFB3 promoter. Moreover, PFKFB3 mRNA transcription induction is insensitive to the ERK inhibitor PD98059, and the 30-nt SRE wild-type sequence is sufficient to induce luciferase activity in an isolated system. Thus it seems that anisomycin-induced expression of the PFKFB3 promoter can be attributed to direct SRF phosphorylation and binding to its consensus sequence independently of ternary complex factors. Taken together, the results of the present study demonstrate for the first time functional effects of MK2-dependent phosphorylation of SRF at Ser 103 in transcriptional activation of the PFKFB3 gene.
Consistently, the Fru-2,6-P 2 concentration increased shortly (15 min) after treatment with stress stimuli. This rapid increase in Fru-2,6-P 2 concentration correlated with the phosphorylation time course of the PFKFB3 isoenzyme at Ser 461 . Both effects were dependent on the p38/MK2 pathway since they could be abrogated by SB203580 and PF3644022 inhibitors. The C-terminal region around Ser 461 of PFKFB3, also conserved in the PFKFB2 isoenzyme, contains two putative phosphorylation sites (Ser 461 and Ser 478 ) that can be phosphorylated by several protein kinases [3] . The first serine residue can be phosphorylated by AMPK in both isoenzymes [19, 20] . Recently, we demonstrated phosphorylation of Ser 461 of PFKFB3 in response to progestins by RSK [16] . MK2 phosphorylated PFKFB3 kinetics were found to be altered with an increase in V max of PFK-2 and a decreased K m value for Fru-6-P. Mass spectrometric analysis identified the phosphorylated residue as Ser 461 . Moreover, mutation of Ser 461 into glutamate, which structurally mimics a phosphorylated serine residue, increased PFK-2 activity, Fru-2,6-P 2 concentration and lactate production compared with non-phosphorylated Ser 461 , indicating enhanced glycolytic flux. PFKFB3 is expressed ubiquitously and is present in proliferating tissues [11, 12, 39] , transformed cells [4, 5, 7] and in various solid tumours and leukaemias [13, 15] . The PFKFB3 isoenzyme is degraded through the ubiquitinproteasome proteolytic pathway [40] , through the E3 ubiquitin ligase APC/Cdh1 (anaphase-promoting complex/cyclosome) [41] , linking cell-cycle progression and the metabolic response that underpins it. Furthermore, the PFKFB3 isoenzyme was found to be regulated through the PI3K/Akt/mTOR (mammalian target of rapamycin) pathway [12, 42] , and to be localized to the nucleus of several transformed cells, where it regulates proliferation via cyclin-dependent kinases [39] . Furthermore, the inhibition of its expression reduces cell proliferation and tumour growth in animal models [13, 14] . Taken together, these results indicate that Fru-2,6-P 2 is essential to the maintenance of glycolytic flux necessary for providing energy and biosynthetic precursors to dividing cells.
In conclusion, the results of the present study show for the first time the modulation of glycolysis by the p38/MK2 MAPK pathway through a dual regulation of PFKFB3 isoenzyme. At a post-translational level, via phosphorylation of the enzyme at Ser 461 , and transcriptionally, through the binding of SRF to the consensus SRE present in the PFKFB3 promoter, displaying a new mechanism by which cancer cells can adapt to their environment and conferring a proliferative advantage with respect to nontumoral cells. Moreover, these results reinforce the essential role of PFKFB3 in the glycolytic phenotype of cancer cells to facilitate adaptation of tumour cells to the microenvironmental conditions, such as hypoxia or nutrient restriction, giving a proliferative advantage with respect to non-tumoral cells.
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